Testmiljö
Observera att detta är en testmiljö för utveckling som inte ska användas som underlag för klinisk bedömning. Besök Janusmed här: https://janusmed.se

11/21/2024

Janusmed fosterpåverkan

Janusmed fosterpåverkan – Aminophylline

Janusmed fosterpåverkan tillhandahåller bedömningar av eventuella risker för fostret, när en gravid kvinna använder olika läkemedel. Observera att texterna är generella, och att en bedömning måste göras i varje enskilt fall. Om du inte är medicinskt utbildad, läs först vår information för patienter och allmänhet.

För att komma till startsidan för Janusmed fosterpåverkan och för att göra sökningar klicka här.

Tillbaka till index
2 2
2 2

Teofyllin Testmiljö

Teofyllin

Klass : 2

Visa all info

Skriv ut

Kontakta oss

  1. Dombrowski MP, Schatz M, Wise R, Thom EA, Landon M, Mabie W et al. Randomized trial of inhaled beclomethasone dipropionate versus theophylline for moderate asthma during pregnancy. Am J Obstet Gynecol. 2004;190(3):737-44.

  2. Heinonen OP, Slone D, Shapiro S. Birth Defects and Drugs in Pregnancy. Publishing Sciences Group, Littleton, Mass. 1977.

  3. M Schatz, R S Zeiger, K Harden, C C Hoffman, L Chiligar, D Petitti. The safety of asthma and allergy medications during pregnancy. J Allergy Clin Immunol. 1997 09;100(3):301-6.

  4. B Stenius-Aarniala, S Riikonen, K Teramo. Slow-release theophylline in pregnant asthmatics. Chest. 1995 03;107(3):642-7.

  5. Källén B, Otterblad Olausson P. Use of anti-asthmatic drugs during pregnancy. 3: Congenital malformations in the infants. Eur J Clin Pharmacol 2007;63:383-8.

  6. Czeizel AE, Puhó E, Bártfai Z, Somoskövi A. A Possible Association between Oral Aminophylline Treatment during Pregnancy and Skeletal Congenital Abnormalities. Clin Drug Investig. 2003;23(12):803-16.

  7. Park JM, Schmer V, Myers TL. Cardiovascular anomalies associated with prenatal exposure to theophylline. South Med J. 1990;83(12):1487-8.

  8. Rosa F. Databases in the assessment of the effects of drugs during pregnancy. J Allergy Clin Immunol. 1999;103(103):S360-1.

  9. Ali Z, Hansen AV, Ulrik CS. Exacerbations of asthma during pregnancy: Impact on pregnancy complications and outcome. J Obstet Gynaecol. 2015:1-7.

  10. Liu S, Wen SW, Demissie K, Marcoux S, Kramer MS. Maternal asthma and pregnancy outcomes: A retrospective cohort study. Am J Obstet Gynecol 2001;184:90-6.

  11. Kallen B, Rydhstroem H, Aberg A. Asthma during pregnancy - a population based study. Eur J Epidemiol 2000;16:167-71.

  12. Källén B. The safety of asthma medications during pregnancy. Expert Opin Drug Saf 2007;6:15-26.

  13. Källén B, Otterblad Olausson P. Use of anti-asthmatic drugs during pregnancy. 1: Maternal characteristics, pregnancy and delivery complications. Eur J Clin Pharmacol 2007;63:363-73.

  14. Källén B, Otterblad Olausson P. Use of anti-asthmatic drugs during pregnancy. 2: Infant characteristics excluding congenital malformations. Eur J Clin Pharmacol 2007;63:375-81.

  1. Dombrowski MP, Schatz M, Wise R, Thom EA, Landon M, Mabie W et al. Randomized trial of inhaled beclomethasone dipropionate versus theophylline for moderate asthma during pregnancy. Am J Obstet Gynecol. 2004;190(3):737-44.
  2. Heinonen OP, Slone D, Shapiro S. Birth Defects and Drugs in Pregnancy. Publishing Sciences Group, Littleton, Mass. 1977.
  3. M Schatz, R S Zeiger, K Harden, C C Hoffman, L Chiligar, D Petitti. The safety of asthma and allergy medications during pregnancy. J Allergy Clin Immunol. 1997 09;100(3):301-6.
  4. B Stenius-Aarniala, S Riikonen, K Teramo. Slow-release theophylline in pregnant asthmatics. Chest. 1995 03;107(3):642-7.
  5. Källén B, Otterblad Olausson P. Use of anti-asthmatic drugs during pregnancy. 3: Congenital malformations in the infants. Eur J Clin Pharmacol 2007;63:383-8.
  6. Czeizel AE, Puhó E, Bártfai Z, Somoskövi A. A Possible Association between Oral Aminophylline Treatment during Pregnancy and Skeletal Congenital Abnormalities. Clin Drug Investig. 2003;23(12):803-16.
  7. Park JM, Schmer V, Myers TL. Cardiovascular anomalies associated with prenatal exposure to theophylline. South Med J. 1990;83(12):1487-8.
  8. Rosa F. Databases in the assessment of the effects of drugs during pregnancy. J Allergy Clin Immunol. 1999;103(103):S360-1.
  9. Ali Z, Hansen AV, Ulrik CS. Exacerbations of asthma during pregnancy: Impact on pregnancy complications and outcome. J Obstet Gynaecol. 2015:1-7.
  10. Liu S, Wen SW, Demissie K, Marcoux S, Kramer MS. Maternal asthma and pregnancy outcomes: A retrospective cohort study. Am J Obstet Gynecol 2001;184:90-6.
  11. Kallen B, Rydhstroem H, Aberg A. Asthma during pregnancy - a population based study. Eur J Epidemiol 2000;16:167-71.
  12. Källén B. The safety of asthma medications during pregnancy. Expert Opin Drug Saf 2007;6:15-26.
  13. Källén B, Otterblad Olausson P. Use of anti-asthmatic drugs during pregnancy. 1: Maternal characteristics, pregnancy and delivery complications. Eur J Clin Pharmacol 2007;63:363-73.
  14. Källén B, Otterblad Olausson P. Use of anti-asthmatic drugs during pregnancy. 2: Infant characteristics excluding congenital malformations. Eur J Clin Pharmacol 2007;63:375-81.